Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in American Samoa
American Samoa: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.4% in 2024. ▲ Rising
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in American Samoa, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
American Samoa recorded 0.4% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the lowest value across all 10 years on record.
That represents a change of unchanged over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in American Samoa peaked at 0.5% in 2018 and was at its lowest, 0.4%, in 2015.
That places American Samoa 59th out of 215 countries with data for 2024, putting it in the middle of the range.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in American Samoa, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.4% | — |
| 2016 | 0.4% | +0.0% |
| 2017 | 0.4% | +0.0% |
| 2018 | 0.5% | +25.0% |
| 2019 | 0.5% | +0.0% |
| 2020 | 0.5% | +0.0% |
| 2021 | 0.5% | +0.0% |
| 2022 | 0.5% | +0.0% |
| 2023 | 0.4% | -20.0% |
| 2024 | 0.4% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.4% | 0.4% | 0.5% | 5 |
| 2020s | 0.5% | 0.4% | 0.5% | 5 |
Countries ranked near American Samoa
More development goals data for American Samoa
- Red List Index 0.8081 (2025)
- Domestic material consumption, by type of raw material 7,358 (2024)
- DEC alternative conversion factor 1 (2024)
- Domestic material consumption per capita, by type of raw material 0.1573 (2024)
- Number of victims of intentional homicide, by sex 0 (2019)
- Number of victims of intentional homicide per 100,000 population, by 0 (2019)
- Average tariff applied by developed countries, most-favored nation 6.3% (2024)
- Average tariff applied by developed countries, preferential status 5.6% (2024)
- Chlorophyll-a deviations, remote sensing 0.0% (2022)
- Annual mean levels of fine particulate matter (population-weighted) 6.32 (2023)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in American Samoa?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in American Samoa was 0.4% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in American Samoa?
- The highest recorded value was 0.5% in 2018.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in American Samoa?
- The lowest recorded value was 0.4% in 2015.
- How does American Samoa rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- American Samoa ranks 59th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in American Samoa?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this American Samoa data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).